» Journals » Asian Pac J Cancer Prev

Asian Pacific Journal of Cancer Prevention : Apjcp

The Asian Pacific Journal of Cancer Prevention (APJCP) is a renowned scientific journal dedicated to advancing knowledge and understanding of cancer prevention and control in the Asia-Pacific region. It publishes high-quality research articles, reviews, and commentaries, covering various aspects of cancer epidemiology, risk factors, early detection, treatment, and public health interventions. APJCP serves as a valuable resource for researchers, clinicians, and policymakers working towards reducing the burden of cancer in this diverse and populous region.

Details
Abbr. Asian Pac J Cancer Prev
Start 2000
End Continuing
Frequency Quarterly, <2001->
p-ISSN 1513-7368
e-ISSN 2476-762X
Country Thailand
Language English
Specialty Oncology
Metrics
h-index / Ranks: 3601 91
SJR / Ranks: 9694 446
CiteScore / Ranks: 8566 3.00
Recent Articles
1.
Kadian J, Kaushik M, Singh A
Asian Pac J Cancer Prev . 2025 Mar; 26(2):701-711. PMID: 40022720
Background: The largest organ, skin, acts as the body's first line of protection against various environmental threats and harmful substances, which may be carcinogenic. The widespread acceptance of conventional chemotherapy...
2.
Espenbetova M, Bidakhmetova A, Krykpayeva A, Yespenbetova B, Toleutayeva D, Serikbayev A, et al.
Asian Pac J Cancer Prev . 2025 Mar; 26(2):691-699. PMID: 40022719
Objective: This study aimed to investigate the incidence and mortality of thyroid cancer (TC) in the Republic of Kazakhstan and East Kazakhstan Region, which includes the areas adjacent to the...
3.
Bui T, Pham D, Quang L, Vo N
Asian Pac J Cancer Prev . 2025 Mar; 26(2):685-689. PMID: 40022718
Background: Breast cancer is the most common malignancy in women worldwide, and breast reconstruction following mastectomy is an integral part of patient care to improve quality of life and aesthetic...
4.
Khazeem M
Asian Pac J Cancer Prev . 2025 Mar; 26(2):677-684. PMID: 40022717
Background: Myeloproliferative Neoplasm (MPN) is a clonal disorder of blood progenitor cells during haematopoiesis. JAK2V617F mutation represents one of the major identified genetic reasons of MPN disorder. It has been...
5.
Aggarwal I, Mehta D, Yadav P, Rakheja S, Goel H, Vinod A, et al.
Asian Pac J Cancer Prev . 2025 Mar; 26(2):671-676. PMID: 40022716
Objective: In India, majority of cancer-related deaths are attributed to Human Papillomavirus (HPV), which is preventable through vaccines such as Gardasil and Gardasil 9. Despite their efficacy, uptake of these...
6.
Toska A, Georga D, Christakis A, Fradelos E, Rouka E, Sarafis P, et al.
Asian Pac J Cancer Prev . 2025 Mar; 26(2):663-670. PMID: 40022715
Background: Breast cancer is the most prevalent cancer among women in Greece. It is crucial to have a simple, trustworthy and effective instrument for assessing the factors that impact cancer...
7.
Shandilya P, Vidyarthi A, Ash H, Kumar A, Ketan V
Asian Pac J Cancer Prev . 2025 Mar; 26(2):657-661. PMID: 40022714
Background: Tumour manipulation during surgery can lead to the dissemination of malignant cells and potential wound contamination. Despite the widespread practice of irrigating surgical sites with normal saline, the efficacy...
8.
Khazaei Z, Goodarzi E, Momenabadi V, Asadilari F, Mirshekarpour H, Abbasi R, et al.
Asian Pac J Cancer Prev . 2025 Mar; 26(2):647-656. PMID: 40022713
Introduction: Colon cancer is the third most common malignancy worldwide, which is increasing in middle-income countries. Our aim in this study was to investigate the association between socioeconomic inequality and...
9.
Yahia S, Tahari Z, Medjdoub A, Bessaih N, Messatfa M, Raiah M, et al.
Asian Pac J Cancer Prev . 2025 Mar; 26(2):639-646. PMID: 40022712
Objective: Breast cancer (BC) is a heterogeneous disease, recognized as a major public health problem worldwide, with several risk factors including oxidative stress, an imbalance between the production of reactive...
10.
Dewan A, Kumar L, Chufal K, Bhushan M, Ahmad I, Barik S, et al.
Asian Pac J Cancer Prev . 2025 Mar; 26(2):631-638. PMID: 40022711
Objective: To analyse the dosimetric benefit achieved with Deep inspiratory breath hold (DIBH) for left sided breast irradiation and to identify the factors impacting it. Methods: Between 1st January'2023 to...